Fundamental Analysis
35 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.6% | -21.9% | 1 / 3 | -2.5% | +1.54 pp | +0.18 pp | +14.4% | 1.46 | 5.92 | 336 | −2,5% | 9,0 | +4,6% | 5.92 | 7.48 | −20,9% |
| Pts | 0 | 0 | 4 | 0 | 8 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 20.000 (close price on 2026-10-19)EPS (TTM): 3.379
Financial charts
1.Revenue & growth
VND bn336Q2/26
1.Revenue & growth
VND bn336Q2/26
2.Profit & growth
VND bn9,04Q2/26
3.Profit mix (Penman)
VND bn122Q2/26
4.Margins & cost structure
%30.6%Q2/26
5.Returns & cash cycle
% · days9.9%Q2/26
6.Earnings quality & cash
VND bn259Q2/26
7.Asset structure
VND bn2.005Q2/26
8.Funding & debt health
VND bn · times2.005Q2/26
9.Revenue backlog
VND bn12,0Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %301Q2/26
Adjusted EPS growth, latest quarter
5.2%
Average adjusted EPS growth, 3 quarters
-21.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26